PMH13- THE DIRECT COST OF RISPERIDONE VERSUS HALOPERIDOL THERAPY FOR CHRONIC SCHIZOPHRENIA IN POLAND
Sep 1, 2001, 00:00 AM
10.1016/S1098-3015(11)71622-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)71622-9/fulltext
Section Title :
Section Order :
136
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71622-9&doi=10.1016/S1098-3015(11)71622-9